2r 3r 4s 5r 5 6 amino 2 chloropurin 9 yl 4 fluoro 2 hydroxymethyl oxolan 3 ol, 2 chloro 9 2 deoxy 2 fluoro beta d arabinofuranosyl adenine, 2 chloro 9 2 deoxy 2 fluoro beta d arabinofuranosyl adenine
For the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphocytic (lymphoblastic) leukemia after at least two prior regimens. It is designated...